Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Peter L Anderson

Showing results (1-10 of 270) with videos related to

Pageof 27
Sort By:
Eclinicalmedicine|June 14, 2019
What Can Urine Tell Us About Medication Adherence?Peter L Anderson
The Annals of Pharmacotherapy|October 14, 2004
Pharmacologic perspectives for once-daily antiretroviral therapyPeter L Anderson
Current Opinion in HIV and AIDS|April 18, 2009
Recent developments in the clinical pharmacology of anti-HIV nucleoside analogsPeter L Anderson
Positively Aware : the Monthly Journal of the Test Positive Aware Network|April 15, 2005
The ABC's of pharmacokineticsPeter L Anderson
Journal of the International AIDS Society|November 26, 2024
Adherence measurement considerations for oral antiretroviral medicationsCorwin Coppinger, Peter L Anderson
Expert Opinion on Drug Metabolism & Toxicology|January 6, 2025
Considerations for drug-drug interactions between long-acting antiretrovirals and immunosuppressants for solid organ transplantationCorwin Coppinger, Peter L Anderson
Clinical Pharmacology and Therapeutics|September 5, 2018
Pharmacologic-Based Methods of Adherence Assessment in HIV PreventionKristina M Brooks, Peter L Anderson
The Journal of Infectious Diseases|December 9, 2025
On-Demand Dosing of HIV Preexposure Prophylaxis for Women: Has Their Time Finally Come?Susan P Buchbinder, Peter L Anderson
Current HIV/AIDS Reports|August 11, 2005
Updated clinical pharmacologic considerations for HIV-1 protease inhibitorsPeter L Anderson, Courtney V Fletcher
Expert Opinion on Drug Metabolism & Toxicology|April 7, 2020
Pharmacology and drug interactions with HIV PrEP in transgender persons receiving gender affirming hormone therapyJenna L Yager, Peter L Anderson
Pageof 27

Showing results (1-10 of 270) with videos related to

Sort By:
Pageof 27
Eclinicalmedicine|June 14, 2019
What Can Urine Tell Us About Medication Adherence?Peter L Anderson
The Annals of Pharmacotherapy|October 14, 2004
Pharmacologic perspectives for once-daily antiretroviral therapyPeter L Anderson
Current Opinion in HIV and AIDS|April 18, 2009
Recent developments in the clinical pharmacology of anti-HIV nucleoside analogsPeter L Anderson
Positively Aware : the Monthly Journal of the Test Positive Aware Network|April 15, 2005
The ABC's of pharmacokineticsPeter L Anderson
Journal of the International AIDS Society|November 26, 2024
Adherence measurement considerations for oral antiretroviral medicationsCorwin Coppinger, Peter L Anderson
Expert Opinion on Drug Metabolism & Toxicology|January 6, 2025
Considerations for drug-drug interactions between long-acting antiretrovirals and immunosuppressants for solid organ transplantationCorwin Coppinger, Peter L Anderson
Clinical Pharmacology and Therapeutics|September 5, 2018
Pharmacologic-Based Methods of Adherence Assessment in HIV PreventionKristina M Brooks, Peter L Anderson
The Journal of Infectious Diseases|December 9, 2025
On-Demand Dosing of HIV Preexposure Prophylaxis for Women: Has Their Time Finally Come?Susan P Buchbinder, Peter L Anderson
Current HIV/AIDS Reports|August 11, 2005
Updated clinical pharmacologic considerations for HIV-1 protease inhibitorsPeter L Anderson, Courtney V Fletcher
Expert Opinion on Drug Metabolism & Toxicology|April 7, 2020
Pharmacology and drug interactions with HIV PrEP in transgender persons receiving gender affirming hormone therapyJenna L Yager, Peter L Anderson
Pageof 27